In Brief: EP Technologies
This article was originally published in The Gray Sheet
Executive Summary
EP Technologies: Radiofrequency ablation device firm announces Oct. 6 that it is "in discussions with respect to a possible business combination at a price of $13 per share." The price would give the deal a value of roughly $150 mil., about six times EP Technologies' current revenues, but it would represent a discount to the $16 per share closing price of the company's stock on Oct. 5. EPT stock has gained value recently on takeover speculation. EPT is one of two firms -- the other is Medtronic -- with FDA approval for an RF ablation system for treatment of tachyarrhythmias. Potential buyers could include Boston Scientific, St. Jude, and Johnson & Johnson...